Timothy P. Walbert - May 6, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Chairman, President and CEO, Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
May 6, 2022
Transactions value $
-$508,506
Form type
4
Date filed
5/10/2022, 05:59 PM
Previous filing
May 4, 2022
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise $164K +7.4K +1.61% $22.14 468K May 6, 2022 Direct
transaction HZNP Ordinary Shares Sale -$217K -2.4K -0.51% $90.33 466K May 6, 2022 Direct F1, F2
transaction HZNP Ordinary Shares Sale -$456K -5K -1.07% $91.11 461K May 6, 2022 Direct F1
holding HZNP Ordinary Shares 108K May 6, 2022 See footnote F3
holding HZNP Ordinary Shares 100K May 6, 2022 See footnote F4
holding HZNP Ordinary Shares 40.9K May 6, 2022 By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Stock Option (Right to Buy) Options Exercise $0 -7.4K -0.91% $0.00 810K May 6, 2022 Ordinary Shares 7.4K $22.14 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 1, 2021.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.9 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The shares are held by the Timothy P. Walbert 2021 Gift Trust, of which the Reporting Person's spouse is the Trustee and beneficiary.
F4 The shares are held by the Keli B. Walbert 2021 Gift Trust, of which the Reporting Person is the Trustee. The beneficiaries of the Trust include the Reporting Person and his descendants.
F5 The stock option is fully vested and exercisable.